company background image
3154

Medius Holdings TSE:3154 Stock Report

Last Price

JP¥695.00

Market Cap

JP¥15.2b

7D

0.4%

1Y

-27.1%

Updated

24 Sep, 2022

Data

Company Financials
3154 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health3/6
Dividends3/6

3154 Stock Overview

Medius Holdings Co., Ltd. operates in the medical care industry in Japan.

Medius Holdings Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medius Holdings
Historical stock prices
Current Share PriceJP¥695.00
52 Week HighJP¥1,097.00
52 Week LowJP¥690.00
Beta0.41
1 Month Change-14.30%
3 Month Change-28.79%
1 Year Change-27.15%
3 Year Change-3.87%
5 Year Change-23.93%
Change since IPO190.93%

Recent News & Updates

Shareholder Returns

3154JP HealthcareJP Market
7D0.4%-2.0%-1.1%
1Y-27.1%-13.4%-9.1%

Return vs Industry: 3154 underperformed the JP Healthcare industry which returned -13.4% over the past year.

Return vs Market: 3154 underperformed the JP Market which returned -9.1% over the past year.

Price Volatility

Is 3154's price volatile compared to industry and market?
3154 volatility
3154 Average Weekly Movement5.5%
Healthcare Industry Average Movement3.4%
Market Average Movement3.5%
10% most volatile stocks in JP Market7.4%
10% least volatile stocks in JP Market1.8%

Stable Share Price: 3154 is more volatile than 75% of JP stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 3154's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of JP stocks.

About the Company

FoundedEmployeesCEOWebsite
20092,002Yasuhiko Ikeyahttps://www.medius.co.jp

Medius Holdings Co., Ltd. operates in the medical care industry in Japan. The company sells medical equipment, such as syringes, gauze, other necessary medical consumables, and advanced medical system; and provides repair, after-sales, and maintenance services for medical equipment to hospitals and other medical facilities. It is also involved in the sale and rental of nursing care and welfare equipment to hospitals, nursing care facilities, and general individuals; and sale and rental of on-board medical instruments for ambulance, AEDs, and other emergency supplies and equipment with high social needs.

Medius Holdings Fundamentals Summary

How do Medius Holdings's earnings and revenue compare to its market cap?
3154 fundamental statistics
Market CapJP¥15.24b
Earnings (TTM)JP¥1.87b
Revenue (TTM)JP¥221.69b

8.2x

P/E Ratio

0.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
3154 income statement (TTM)
RevenueJP¥221.69b
Cost of RevenueJP¥194.27b
Gross ProfitJP¥27.42b
Other ExpensesJP¥25.55b
EarningsJP¥1.87b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Nov 08, 2022

Earnings per share (EPS)85.16
Gross Margin12.37%
Net Profit Margin0.84%
Debt/Equity Ratio102.9%

How did 3154 perform over the long term?

See historical performance and comparison

Dividends

2.7%

Current Dividend Yield

25%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is 3154 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3154?

Other financial metrics that can be useful for relative valuation.

3154 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.1x
Enterprise Value/EBITDA7x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 3154's PE Ratio compare to its peers?

3154 PE Ratio vs Peers
The above table shows the PE ratio for 3154 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average9.9x
3055 Hokuyaku Takeyama HoldingsInc
5xn/aJP¥15.1b
3417 Ohki Healthcare HoldingsLtd
9.3xn/aJP¥10.2b
2393 Nippon Care Supply
14.7xn/aJP¥23.3b
9273 Koa Shoji HoldingsLtd
10.8x7.9%JP¥25.5b
3154 Medius Holdings
8.2xn/aJP¥15.2b

Price-To-Earnings vs Peers: 3154 is good value based on its Price-To-Earnings Ratio (8.2x) compared to the peer average (9.9x).


Price to Earnings Ratio vs Industry

How does 3154's PE Ratio compare vs other companies in the JP Healthcare Industry?

Price-To-Earnings vs Industry: 3154 is good value based on its Price-To-Earnings Ratio (8.2x) compared to the JP Healthcare industry average (11.9x)


Price to Earnings Ratio vs Fair Ratio

What is 3154's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3154 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio8.2x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 3154's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 3154 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 3154 (¥695) is trading above our estimate of fair value (¥467.81)

Significantly Below Fair Value: 3154 is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Medius Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


7.0%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medius Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Take a look at our analysis of 3154’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.

Past Performance

How has Medius Holdings performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


32.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 3154 has a high level of non-cash earnings.

Growing Profit Margin: 3154's current net profit margins (0.8%) are higher than last year (0.8%).


Past Earnings Growth Analysis

Earnings Trend: 3154's earnings have grown significantly by 32.6% per year over the past 5 years.

Accelerating Growth: 3154's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 3154 had negative earnings growth (-9.6%) over the past year, making it difficult to compare to the Healthcare industry average (12%).


Return on Equity

High ROE: 3154's Return on Equity (10.8%) is considered low.


Discover strong past performing companies

Financial Health

How is Medius Holdings's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 3154's short term assets (¥71.6B) exceed its short term liabilities (¥67.5B).

Long Term Liabilities: 3154's short term assets (¥71.6B) exceed its long term liabilities (¥8.1B).


Debt to Equity History and Analysis

Debt Level: 3154's net debt to equity ratio (50.3%) is considered high.

Reducing Debt: 3154's debt to equity ratio has increased from 38.5% to 102.9% over the past 5 years.

Debt Coverage: 3154's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: 3154's interest payments on its debt are well covered by EBIT (126x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Medius Holdings's current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


2.73%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 3154's dividend (2.73%) is higher than the bottom 25% of dividend payers in the JP market (1.65%).

High Dividend: 3154's dividend (2.73%) is low compared to the top 25% of dividend payers in the JP market (3.66%).


Stability and Growth of Payments

Stable Dividend: 3154's dividend payments have been volatile in the past 10 years.

Growing Dividend: 3154's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (24.6%), 3154's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: 3154 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

12.6yrs

Average management tenure


CEO

Yasuhiko Ikeya (68 yo)

13.17yrs

Tenure

Yasuhiko Ikeya has been the President and Chief Executive Officer at Medius Holdings Co., Ltd. since July 2009 and September 2010 respectively. Yasuhiko Ikeya has been with Shizuoka Institute of Medical In...


Leadership Team

Experienced Management: 3154's management team is seasoned and experienced (12.6 years average tenure).


Board Members

Experienced Board: 3154's board of directors are seasoned and experienced ( 12 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 24 shareholders own 49.27% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.67%
Shuhei Miyaji
2,558,000¥1.8b0%no data
10.72%
Yasuhiko Ikeya
2,351,000¥1.6b0%no data
10.49%
Masaru Kuribara
2,299,752¥1.6b0%no data
5.07%
Kyowa Medical Corp., ESOP
1,111,000¥772.1m0%no data
2.27%
Kuribara Medical Instruments Co., Ltd. ESOP
497,000¥345.4m0%no data
1.81%
Ryouko Noda
396,000¥275.2m0%no data
1.74%
Alfresa Holdings Corporation
382,000¥265.5m0%no data
1.7%
Nomura Asset Management Co., Ltd.
372,500¥258.9m-0.4%no data
0.78%
Daiwa Asset Management Co. Ltd.
172,000¥119.5m0.35%no data
0.78%
Nikko Asset Management Co., Ltd.
170,800¥118.7m-1.21%no data
0.64%
Eiji Shibata
139,452¥96.9m0%no data
0.51%
Dimensional Fund Advisors LP
112,312¥78.1m0%no data
0.33%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
71,600¥49.8m0.7%no data
0.29%
Masami Kobayashi
62,560¥43.5m0%no data
0.19%
Hiroyuki Akutagawa
41,452¥28.8m0%no data
0.082%
Asset Management One Co., Ltd.
18,000¥12.5m7.78%no data
0.068%
BlackRock, Inc.
14,900¥10.4m35.45%no data
0.045%
Sumitomo Mitsui Trust Asset Management Co., Ltd.
9,800¥6.8m0%no data
0.028%
Mitsuo Yamaguchi
6,200¥4.3m0%no data
0.024%
Norinchukin-Zenkyoren Asset Management Co., Ltd.
5,200¥3.6m0%no data
0.021%
Hisayuki Furuki
4,556¥3.2m0%no data
0.015%
Amundi Asset Management
3,185¥2.2m0%no data
0.0055%
Resona Asset Management Co., Ltd.
1,200¥834.0k0%no data
0.005%
Hitachi Investment Management, Ltd.
1,100¥764.5k0%no data

Company Information

Medius Holdings Co., Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: Medius Holdings Co., Ltd.
  • Ticker: 3154
  • Exchange: TSE
  • Founded: 2009
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Implied Market Cap: JP¥15.237b
  • Shares outstanding: 21.92m
  • Website: https://www.medius.co.jp

Number of Employees


Location

  • Medius Holdings Co., Ltd.
  • 1-1-1 Kyobashi
  • 3rd Floor
  • Tokyo
  • 104-0031
  • Japan


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
3154TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYSep 2006

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/24 00:00
End of Day Share Price2022/09/22 00:00
Earnings2022/06/30
Annual Earnings2022/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.